Listed

Lipocine Inc.

LPCNNasdaqCIK 1535955HealthcareFiscal year ends Dec 31

Reports and events: 514 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Lipocine Inc., Reports and events
FiledFormWhat it isAccession number
2025-06-0910:13 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001641172-25-014224
2025-06-0420:05 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001641172-25-013603
2025-05-2213:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001641172-25-012000
2025-05-1413:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001641172-25-010118
2025-05-1221:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001641172-25-009772
2025-05-0813:30 ET10-QQuarterly reportPeriod 2025-03-310001641172-25-009180
2025-05-0813:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001641172-25-009179
2025-05-0613:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001641172-25-008766
2025-04-2213:30 ETDEF 14AProxy statementPeriod 2024-12-310001641172-25-005633
2025-04-0320:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001641172-25-002581
2025-03-2613:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001641172-25-000693
2025-03-1313:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-25-010149
2025-03-1313:30 ET10-KAnnual reportPeriod 2024-12-310001493152-25-010146
2025-03-1213:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-25-009955
2025-02-1114:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-25-005809
2025-02-0614:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-25-005108
2025-01-1311:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-25-001841
2024-12-1714:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-050346
2024-12-1311:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-049874
2024-11-1814:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-046444
2024-11-0714:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-043936
2024-11-0711:09 ET10-QQuarterly reportPeriod 2024-09-300001493152-24-043893
2024-11-0521:37 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-043670
2024-10-3113:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-043147
2024-10-2322:38 ET8-K1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-24-042117
2024-10-1620:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-041294
2024-10-1010:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-040651
2024-10-0813:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-040395
2024-10-0801:39 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-040365
2024-10-0213:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-039133
2024-09-3013:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-038728
2024-09-0513:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-035104
2024-08-2715:23 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-033967
2024-08-0810:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-030649
2024-08-0810:19 ET10-QQuarterly reportPeriod 2024-06-300001493152-24-030648
2024-08-0720:05 ET8-K/A5.07 Shareholder vote results0001493152-24-030545
2024-06-2512:15 ET8-K8.01 Other events0001493152-24-025037
2024-06-1013:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-023289
2024-06-0520:32 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-24-022767
2024-06-0321:15 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-022416
2024-05-0910:06 ET10-QQuarterly reportPeriod 2024-03-310001493152-24-018311
2024-05-0910:03 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-018306
2024-05-0810:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-018153
2024-05-0113:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-017361
2024-04-2913:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-016868
2024-04-2621:20 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001493152-24-016777
2024-04-2320:05 ETDEF 14AProxy statementPeriod 2024-04-230001493152-24-015694
2024-04-1111:24 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-014273
2024-03-2810:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-011600
2024-03-2510:14 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-011053

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.